Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or‐Yam Revach, Seth Anderson, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 158-167
Open Access | Times Cited: 86

Showing 26-50 of 86 citing articles:

Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine
Ziyi Zhu, John Paul Shen, Paul Chi-Lui Ho, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Mutational Profile of Blood and Tumor Tissue and Biomarkers of Response to PD-1 Inhibitors in Patients with Cutaneous Squamous Cell Carcinoma
Mark J. Chang, Daniel B. Stamos, Cetin Urtis, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1172-1172
Open Access
Structure-Based Optimization of TBK1 Inhibitors
Wenxuan Sun, Yuting Xie, Qiancheng Xia, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
Role of IFN-α in Rheumatoid Arthritis
Chung Mun Alice Lin, John D. Isaacs, Faye A. H. Cooles
Current Rheumatology Reports (2023) Vol. 26, Iss. 2, pp. 37-52
Open Access | Times Cited: 10
Emerging roles of 3D-culture systems in tackling tumor drug resistance
Amin Nikdouz, Francesca Orso
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 788-804
Open Access | Times Cited: 9
TNF and IFNγ-induced cell death requires IRF1 and ELAVL1 to promote CASP8 expression
Buhao Deng, Jingyi Wang, Tingyun Yang, et al.
The Journal of Cell Biology (2024) Vol. 223, Iss. 3
Open Access | Times Cited: 3
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
Or‐Yam Revach, Angelina M. Cicerchia, Ofir Shorer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Near‐Infrared‐II Nanomaterials for Activatable Photodiagnosis and Phototherapy
Wanying Jiang, Lisheng Lin, Ping Wu, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 33
Closed Access | Times Cited: 3
Nanomaterials: leading immunogenic cell death-based cancer therapies
Changyu Ma, Zhe Cheng, Haotian Tan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Necroptosis in immunity, tissue homeostasis, and cancer
Jinwen Yin, Yuqiang Yu, Xinyue Huang, et al.
Current Opinion in Immunology (2024) Vol. 89, pp. 102455-102455
Closed Access | Times Cited: 3
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Recent highlights of cancer immunotherapy
Xianqun Fan
Holistic Integrative Oncology (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 7
Applications and evolution of 3D cancer-immune cell models
Ileana L. Co, Aleksandra Fomina, Michelle Nurse, et al.
Trends in biotechnology (2024)
Closed Access | Times Cited: 2
Tumor intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer
Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3669-3682
Closed Access | Times Cited: 2
Nrf2 in human cancers: biological significance and therapeutic potential
Yu Tian, Lixin Tang, Xin Wang, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 8, pp. 3935-3961
Closed Access | Times Cited: 2
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment
Francesca Picca, Claudia Giannotta, Jiahao Tao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10823-10823
Open Access | Times Cited: 2
Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
Wei Zhang, Xiaoqiang Zheng
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Insights into anti-tumor immunity via the polyomavirus shared across human Merkel cell carcinomas
Saumya Jani, Candice D. Church, Paul Nghiem
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Mechanisms controlling the mechanical properties of the nuclei
Giulia Bastianello, Marco Foiani
Current Opinion in Cell Biology (2023) Vol. 84, pp. 102222-102222
Closed Access | Times Cited: 5
Organoids as an Enabler of Precision Immuno-Oncology
Junzhe Zhao, Antoinette Shui Wen Fong, See Voon Seow, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1165-1165
Open Access | Times Cited: 4
In Vitro Three-Dimensional (3D) Models for Melanoma Immunotherapy
G. Nomdedeu-Sancho, А.А. Горкун, N. Mahajan, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5779-5779
Open Access | Times Cited: 4
Targeting GFPT2 to reinvigorate immunotherapy in EGFR-mutated NSCLC
Luyao Ao, Wenjing Jia, Qixing Gong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
Zhian Xiu, Qian Yang, Fusheng Xie, et al.
Journal of Tissue Engineering (2024) Vol. 15
Open Access | Times Cited: 1
Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies
Jui‐Hsiang Hung, Chiao‐Fang Teng, Hsu‐Chin Hung, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 6, pp. 101546-101546
Open Access | Times Cited: 1
Mechanism of TBK1 Activation in Cancer Cells
Lianxin Hu, Qing Zhang
Cell Insight (2024) Vol. 3, Iss. 5, pp. 100197-100197
Open Access | Times Cited: 1

Scroll to top